Deutsche Bank’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.11M | Buy |
|
|||||
|
2025
Q2 | $4.17M | Sell |
|
|||||
|
2025
Q1 | $3.72M | Sell |
|
|||||
|
2024
Q4 | $3.9M | Buy |
|
|||||
|
2024
Q3 | $3.5M | Buy |
|
|||||
|
2024
Q2 | $2.67M | Sell |
|
|||||
|
2024
Q1 | $3.8M | Sell |
|
|||||
|
2023
Q4 | $6.15M | Buy |
|
|||||
|
2023
Q3 | $706K | Buy |
|
|||||
|
2023
Q2 | $628K | Sell |
|
|||||
|
2023
Q1 | $1.18M | Buy |
|
|||||
|
2022
Q4 | $1.25M | Buy |
|
|||||
|
2022
Q3 | $1.09M | Sell |
|
|||||
|
2022
Q2 | $1.09M | Sell |
|
|||||
|
2022
Q1 | $1.81M | Sell |
|
|||||
|
2021
Q4 | $1.69M | Sell |
|
|||||
|
2021
Q3 | $3.05M | Buy |
|
|||||
|
2021
Q2 | $2.24M | Buy |
|
|||||
|
2021
Q1 | $1.32M | Sell |
|
|||||
|
2020
Q4 | $1.07M | Buy |
|
|||||
|
2020
Q3 | $380K | Buy |
|
|||||
|
2020
Q2 | $518K | Sell |
|
|||||
|
2020
Q1 | $4.64M | Sell |
|
|||||
|
2019
Q4 | $13.1M | Buy |
|
|||||
|
2019
Q3 | $1.06M | Buy |
|
|||||
|
2019
Q2 | $896K | Sell |
|
|||||
|
2019
Q1 | $2.03M | Buy |
|
|||||
|
2018
Q4 | $816K | Sell |
|
|||||
|
2018
Q3 | $4.37M | Sell |
|
|||||
|
2018
Q2 | $3.53M | Sell |
|
|||||
|
2018
Q1 | $4.39M | Buy |
|
|||||
|
2017
Q4 | $2.57M | Buy |
|
|||||
|
2017
Q3 | $1.33M | Sell |
|
|||||
|
2017
Q2 | $2.89M | Buy |
|
|||||
|
2017
Q1 | $1.88M | Sell |
|
|||||
|
2016
Q4 | $3.27M | Sell |
|
|||||
|
2016
Q3 | $2.28M | Buy |
|
|||||
|
2016
Q2 | $705K | Sell |
|
|||||
|
2016
Q1 | $817K | Buy |
|
|||||
|
2015
Q4 | $1.03M | Sell |
|
|||||
|
2015
Q3 | $1.54M | Buy |
|
|||||
|
2015
Q2 | $1.35M | Buy |
|
|||||
|
2015
Q1 | $340K | Buy |
|
|||||
|
2014
Q4 | $130K | Sell |
|
|||||
|
2014
Q3 | $400K | Buy |
|
|||||
|
2014
Q2 | $244K | Sell |
|
|||||
|
2014
Q1 | $985K | Buy |
|
|||||
|
2013
Q4 | $157K | Buy |
|
|||||
|
2013
Q3 | $5K | Sell |
|
|||||
|
2013
Q2 | $280K | Buy |
|